Skip to content

Rachel Stockton

A University of Gothenburg study followed 20,000 men for 14 years and found prostate cancer deaths were half as high among those offered PSA screening. Critics point to overdiagnosis: one US study found that for every 20 men treated, only one benefits from early screening.

1 min read

195 stories